PYXS

Pyxis Oncology, Inc. PYXS

PYXS
Pyxis Oncology, Inc. ENTA
Enanta Pharmaceuticals, Inc. IMRX
Immuneering Corporation FHTX
Foghorn Therapeutics Inc. CRBU
Caribou Biosciences, Inc. VYGR
Voyager Therapeutics, Inc. TNYA
Tenaya Therapeutics, Inc. AVIR
Atea Pharmaceuticals, Inc. ZURA
Zura Bio Limited HUMA
Humacyte, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PYXS ENTA IMRX FHTX CRBU VYGR TNYA AVIR ZURA HUMA
6M 250.83 % 98.53 % 204.47 % 1.39 % 54.50 % 32.27 % 34.08 % 0.16 % 239.58 % -50.42 %
YTD 149.11 % 166.37 % 161.76 % -4.58 % 2.08 % -26.88 % -44.15 % -7.46 % 73.40 % -77.32 %
1Y 150.60 % 135.97 % 234.39 % -20.51 % -10.21 % -32.64 % -72.46 % 2.10 % 63.65 % -72.93 %
3Y 269.30 % -66.04 % 26.59 % -31.78 % -77.81 % -24.74 % -66.54 % -27.90 % -43.72 % -54.81 %
5Y -68.11 % -65.23 % -67.11 % -79.48 % -89.49 % -48.13 % -94.83 % -89.69 % -43.72 % -88.08 %
10Y -68.11 % -53.13 % -67.11 % -75.83 % -89.49 % -79.21 % -94.83 % -89.57 % -43.72 % -87.85 %
From the beginning -68.11 % -13.33 % -67.11 % -75.83 % -89.49 % -75.41 % -94.83 % -89.57 % -43.72 % -87.85 %

Dividend